Figure 4From: Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markersOxidative stress markers measured in urine samples collected during treatment with either glimepiride or repaglinide. (A) u-8-OHdG and (B) u-8-isoPGF2α levels are shown (n = 9). *p < 0.05.Back to article page